A 12-Week, Randomised, Double-blind, Multicentre Trial to Evaluate the Efficacy and Safety of ZD4522 (5 and 10 mg), Pravastatin (20 mg), and Simvastatin (20 mg) in the Treatment of Subjects with Hypercholesterolaemia
Study identifier:4522IL/0027
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
A 12-Week, Randomised, Double-blind, Multicentre Trial to Evaluate the Efficacy and Safety of ZD4522 (5 and 10 mg), Pravastatin (20 mg), and Simvastatin (20 mg) in the Treatment of Subjects with Hypercholesterolaemia
Medical condition
dyslipidaemia
Phase
Phase 3
Healthy volunteers
-
Study drug
-
Sex
-
Actual Enrollment
-
Study type
Interventional
Age
-
Date
Study Start Date: 01 Sept 1999
Primary Completion Date: -
Study Completion Date: -
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2013 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
